(EMAILWIRE.COM, August 23, 2018 ) The global transplant diagnostics market is projected to reach USD 4.91 billion by 2023 from USD 3.44 billion in 2018, at a CAGR of 7.4%. The growth witnessed by transplant diagnostics is mainly driven by the increasing public-private funding for target research activities, growing burden of infectious diseases, increasing number of transplant procedures, and technological advancements in the field of transplant diagnostics.

This report broadly segments the market into technology, product, transplant type, application, end user, and region. On the basis of technology, the market is segmented into molecular and non-molecular assay technologies. In 2018, the molecular assay technology segment is expected to account for the largest share of the market. This can be attributed to the expansion in the distribution network of key transplant diagnostic manufacturers across emerging countries (through strategic acquisitions, collaborations, and strengthening manufacturing capabilities) and increasing private funding to develop innovative transplant diagnostic products.

Based on product & service, the market is categorized into reagents & consumables, instruments, and software & services. The reagents & consumables segment accounted for the largest share of the market in 2018. Growing adoption of transplant diagnostic techniques in related research studies and rising number of organ transplantation procedures across major markets are the key factors supporting the growth of the transplant diagnostics market for reagents and consumables.

On the basis of transplant type, the market is categorized into solid organ, stem cell, and soft tissue transplantation. The solid organ transplantation segment accounted for the largest share of the market in 2018. Increasing number of solid organ transplantation procedures, supportive government regulations to augment organ donations across major healthcare markets, and rising number of chronic diseases/disorders that leads to transplantation are the key factors supporting the growth of the market for solid organ transplantation.

This report covers the market across four major regions, namely, North America, Europe, Asia Pacific, and the RoW. North America is expected to command the largest share of the market in 2018. The large share of North America in the global transplant diagnostics market is attributed to the high budgetary allocation for healthcare expenditure, large volume of organ transplantation procedures performed in the region, and technological advancements in the field of transplant diagnostics.

Factors such as high procedural cost of NGS and PCR-based diagnostic assays and limited reimbursements for target procedures are expected to restrain the growth of the market during the forecast period.

The major players in the market are Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), and bioMerieux SA (France).

Get Free Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=2531061

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com